z-logo
open-access-imgOpen Access
A promising new γ-secretase modulator for Alzheimer’s disease
Author(s) -
Justyna A. Dobrowolska Zakaria,
Robert Vassar
Publication year - 2021
Publication title -
the journal of experimental medicine/the journal of experimental medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 8.483
H-Index - 448
eISSN - 1540-9538
pISSN - 0022-1007
DOI - 10.1084/jem.20210077
Subject(s) - disease , population , neuroscience , medicine , biology , environmental health
Effective and safe treatments for Alzheimer's disease (AD) have been an elusive target for scientists who have been working tirelessly to gain control over a disease that is affecting millions of people, with continually rising case numbers as the population ages. However, in this issue of JEM, Rynearson et al. (2021. J. Exp. Med.https://doi.org/10.1084/jem.20202560) present a beacon of hope for this field with a preclinical evaluation of a potent and robust γ-secretase modulator (GSM).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here